Department of Cardiovascular Medicine, British Heart Foundation Experimental Magnetic Resonance Unit (BMRU), Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK.
Heart Fail Rev. 2013 Sep;18(5):657-68. doi: 10.1007/s10741-012-9341-z.
Magnetic resonance spectroscopy (MRS) is the only non-invasive, non-radiation-based technique for investigating the metabolism of living tissue. MRS of protons (1H-MRS), which provides the highest sensitivity of all MR-visible nuclei, is a method capable of detecting and quantifying specific cardiac biomolecules, such as lipids and creatine in normal and diseased hearts in both animal models and humans. This can be used to study mechanisms of heart failure development in a longitudinal manner, for example, the potential contribution of myocardial lipid accumulation in the context of ageing and obesity. Similarly, quantifying creatine levels provides insight into the energy storage and buffering capacity in the heart. Creatine depletion is consistently observed in heart failure independent of aetiology, but its contribution to pathophysiology remains a matter of debate. These and other questions can in theory be answered with cardiac MRS, but fundamental technical challenges have limited its use. The metabolites studied with MRS are much lower concentration than water protons, requiring methods to suppress the dominant water signal and resulting in larger voxel sizes and longer scan times compared to MRI. However, recent technical advances in MR hardware and software have facilitated the application of 1H-MRS in humans and animal models of heart disease as detailed in this review.
磁共振波谱(MRS)是唯一一种用于研究活体组织代谢的非侵入性、非放射性技术。质子磁共振波谱(1H-MRS)是一种能够检测和定量正常和患病心脏中特定心脏生物分子(如脂质和肌酸)的方法,这种方法在动物模型和人类中都具有较高的灵敏度。该方法可用于以纵向方式研究心力衰竭发展的机制,例如,在衰老和肥胖的情况下,心肌脂质积累的潜在贡献。同样,定量肌酸水平可以深入了解心脏的能量储存和缓冲能力。心力衰竭患者无论病因如何都会出现肌酸耗竭,但它对病理生理学的贡献仍存在争议。从理论上讲,心脏 MRS 可以回答这些和其他问题,但基本的技术挑战限制了其应用。与水质子相比,MRS 研究的代谢物浓度要低得多,需要采用方法来抑制主导的水信号,这导致与 MRI 相比,体素尺寸更大,扫描时间更长。然而,磁共振硬件和软件的最新技术进步使得 1H-MRS 在心脏病的人类和动物模型中的应用成为可能,详见本综述。